15 Stocks Moving In Monday's Pre-Market Session

Loading...
Loading...

Gainers

  • Isle of Capri Casinos ISLE rose 21.2 percent to $20.51 in pre-market trading. Eldorado Resorts, Inc. ERI and Isle of Capri Casinos, Inc. struck a merger deal through which the former would buy the latter for $23 a share in cash or 1.638 shares.
  • Avnet, Inc. AVT shares rose 12.2 percent to $44.00 in pre-market trading after the company agreed to sell Technology Solutions business to Tech Data Corp TECD for $2.6 billion.
  • Infoblox Inc BLOX shares rose 15 percent to $26.25 in pre-market trading as the company announced its acquisition by Vista Equity Partners for $26.50 per share in cash.
  • NovaBay Pharmaceuticals, Inc. NBY rose 13.5 percent to $3.95 in pre-market trading after the company disclosed that its Auriclosene has met primary endpoint in Phase 2b trial.
  • Everbridge, Inc. EVBG rose 11.5 percent to $17.00 in pre-market trading after surging 27.08 percent on Friday.
  • Fate Therapeutics Inc FATE rose 10.6 percent to $3.23 in pre-market trading after gaining 4.66 percent on Friday.
  • Geron Corporation GERN rose 9 percent to $2.05 in pre-market trading after dropping 4.57 percent on Friday.
  • Eldorado Resorts Inc ERI shares rose 8.6 percent to $15.47 in pre-market trading. Eldorado Resorts, Inc. and Isle of Capri Casinos, Inc. ISLE struck a merger deal through which the former would buy the latter for $23 a share in cash or 1.638 shares.
  • GoPro Inc GPRO shares rose 4.3 percent to $15.60 in pre-market trading ahead of new product unveiling event.
  • Tech Data Corp TECD rose 3.9 percent to $72.05 in the pre-market trading as the company reached a deal with Avnet, Inc. AVT enabling it to buy the latter's Technology Solutions business. The transaction comprises cash component of $2.4 billion and 2.785 million shares of Tech Data resulting in a total value of about $2.6 billion.
  • CoLucid Pharmaceuticals Inc CLCD rose 3.8 percent to $29.19 in pre-market trading after the company issued an interim update on its Phase 3 GLADIATOR study.
  • General Motors Company GM rose 2.7 percent to $31.80 in pre-market trading. Morgan Stanley upgraded General Motors from Equal-weight to Overweight and raised the price target from $29.00 to $37.00.
  • Radius Health Inc RDUS rose 2.3 percent to $56.39 in the pre-market trading session after the company reported the publication of additional positive results from the Phase 3 ACTIVE trial of Abaloparatide-SC in the JBMR.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

  • Vical Incorporated VICL fell 18.7 percent to $3.14 in pre-market trading after the company disclosed that its Phase 2 trial did not meet primary endpoint.
  • Community Health Systems CYH shares fell 3.2 percent to $11.90 in pre-market trading. Community Health confirmed that it is in preliminary discussions with potential acquirers.
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: NewsMovers & ShakersPre-Market OutlookMarketsMovers#PreMarket GainersLosersTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...